Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slevin

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|July 2, 1998
The in vitro radiosensitivity of human head and neck cancersT Björk-Eriksson, C M West, E Karlsson, et al.
BMJ Open|March 13, 2015
Using a mass media campaign to raise women's awareness of the link between alcohol and cancer: cross-sectional pre-intervention and post-intervention evaluation surveysHelen G Dixon, Iain S Pratt, Maree L Scully, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 20, 2016
Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancerDavid J Thomson, William J Beasley, Kate Garcez, et al.
The Journal of Laryngology and Otology|April 15, 2010
Use of multiple biological markers in radiotherapy-treated head and neck cancerP Silva, N J Slevin, P Sloan, et al.
Head & Neck|September 26, 2000
Metastatic renal cell carcinoma to the nose and paranasal sinusesR Simo, A J Sykes, S P Hargreaves, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 7, 2013
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinomaK K Oguejiofor, J S Hall, N Mani, et al.
British Journal of Cancer|January 5, 2001
Randomized controlled trial to assess the effectiveness of a videotape about radiotherapyR Harrison, P Dey, N J Slevin, et al.
The Journal of Laryngology and Otology|October 25, 2006
Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary?P Silva, P Hulse, A J Sykes, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|July 2, 1998
The in vitro radiosensitivity of human head and neck cancersT Björk-Eriksson, C M West, E Karlsson, et al.
BMJ Open|March 13, 2015
Using a mass media campaign to raise women's awareness of the link between alcohol and cancer: cross-sectional pre-intervention and post-intervention evaluation surveysHelen G Dixon, Iain S Pratt, Maree L Scully, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 20, 2016
Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancerDavid J Thomson, William J Beasley, Kate Garcez, et al.
The Journal of Laryngology and Otology|April 15, 2010
Use of multiple biological markers in radiotherapy-treated head and neck cancerP Silva, N J Slevin, P Sloan, et al.
Head & Neck|September 26, 2000
Metastatic renal cell carcinoma to the nose and paranasal sinusesR Simo, A J Sykes, S P Hargreaves, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 7, 2013
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinomaK K Oguejiofor, J S Hall, N Mani, et al.
British Journal of Cancer|January 5, 2001
Randomized controlled trial to assess the effectiveness of a videotape about radiotherapyR Harrison, P Dey, N J Slevin, et al.
The Journal of Laryngology and Otology|October 25, 2006
Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary?P Silva, P Hulse, A J Sykes, et al.
Pageof 12